This is a preview of subscription content, log in via an institution to check access.
Notes
University of Southampton, Southampton, UK
Reference
Cohen D. Paying twice: questions over high cost of cystic fibrosis drug developed with charitable funding. BMJ : 12 Feb 2014. Available from: URL: http://dx.doi.org/10.1136/bmj.g1445
Rights and permissions
About this article
Cite this article
Ivacaftor price sky high despite charitable funding. PharmacoEcon Outcomes News 697, 3 (2014). https://doi.org/10.1007/s40274-014-1062-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1062-1